- $2.43bn
- $3.53bn
- $1.17bn
NYSE ORDER IMBALANCE 107505.0 SHARES ON BUY SIDE
Brief: Ingevity Invests $60 Mln In Nexeon
Brief: Ingevity To Acquire Ozark Materials For $325 Mln
Brief: Ingevity Reports Q2 Adjusted EPS Of $1.73
Ingevity Corp expected to post earnings of $1.62 a share - Earnings Preview
Brief: Ingevity Announces Changes To Board Of Directors
Brief: Ingevity Appoints Christine Stunyo As Chief Human Resources Officer
Brief: Ingevity Corp - Ingevity Holdings SRL, Ingevity UK Ltd Amended And Restated Credit Agreement
NYSE ORDER IMBALANCE 161205.0 SHARES ON BUY SIDE
Ingevity Corp reports results for the quarter ended in March - Earnings Summary
Brief: Ingevity Reports First Quarter 2022 Financial Results
Ingevity Corp expected to post earnings of $1.04 a share - Earnings Preview
Ingevity Corp reports results for the quarter ended in December - Earnings Summary
Brief: Ingevity Reports Q4 And Full-Year 2021 Results
Ingevity Corp expected to post earnings of 78 cents a share - Earnings Preview
Ingevity Corp reports results for the quarter ended in September - Earnings Summary
Brief: Ingevity Reports Q3 Adj EPS $1.62
Brief: Ingevity Corp Increases Caprolactone Monomer Capacity At Its Warrington, UK Facility
Brief: Ingevity To Challenge Jury Verdict On Emissions Control Patent